| Autor: |
Raman J; Department of Dermatology, University of Florida College of Medicine, Gainesville, FL, USA., Bisbee E; Division of Dermatology, University of Kansas Medical Center, Kansas City, KS, USA., Missall TA; Department of Dermatology, University of Florida College of Medicine, Gainesville, FL, USA., Saikaly SK; Department of Dermatology, University of Florida College of Medicine, Gainesville, FL, USA. |
| Abstrakt: |
Topical imiquimod is used for a variety of common dermatologic lesions, including melanoma in-situ . As an immunomodulator, it is relatively well tolerated with minimal side effects, including scaling, erythema, and edema. Here we present a rare systemic adverse effect, where our patient experienced debilitating severe fatigue when applying imiquimod to a single lesion. Clinicians should be mindful of this side effect and counsel patients appropriately. |
